Circadian biomarker signatures for differentiating unipolar from bipolar depression
Listed in
This article is not in any list yet, why not save it to one of your lists.Abstract
Major depressive disorder (MDD) and bipolar disorder (BD) are often misdiagnosed during depressive episodes, therefore, exploring biomarkers for differential diagnosis is important.
Objective
To identify circadian biomarker signatures in patients’ peripheral blood that differentiate MDD from BD during depressive states.
Design, setting, and participants
This case-control study recruited patients with MDD and BD at depressive state diagnosed by the Diagnostic and Statistical Manual of Mental Disorders Fifth Edition (DSM-5) and Health control (HC) subjects from January 2021 to May 2023. We collected serum samples to detect levels of Period (PER)1/PER2/phosphorylated cAMP reaction element binding protein (pCREB).
Main outcomes and measures
Participants’ clinical data were evaluated by HAMD-17 and MDQ scales. Blood samples ( n = 100) were collected and extracted for serum followed by detecting serum PER1, PER2 and pCREB levels by ELISA.
Results
There were 100 participants in the cohort, including 40 in the MDD group, 30 in the BD group and 30 in the health control (HC) group. 71% were female in the cohort. The mean (SD) serum PER1 level in the HC group was 12.05 (2.96) ng/mL, in the MDD group was 8.41 (2.96) ng/mL, significantly decreased vs the HCs, and in the BPD group that was 16.05 (3.60) ng/mL, significantly increased vs the HCs (adjusted P < 0.0001). The serum pCREB level in the HC group was 205.2 (49.57) ng/mL, in the MDD group was 192.6 (38.52) ng/mL, and that in the BPD group was 290.0 (72.10) ng/mL, which was significantly increased vs the HCs and vs the MDD group. For the differential diagnosis between MDD and BPD, PER1 & pCREB (AUC, 0.9858) show similar high diagnostic efficiency as combined biomarkers of PER1, PER2 & pCREB (AUC, 0.9906).
Conclusions and relevance
This study reveals the importance of serum PER1, combined use of serum PER1 and pCREB as well as that of serum pCREB, PER1 and PER2 in differentiating MDD from BPD.
Key Points
Question
Can major depressive disorder (MDD) be distinguished from bipolar disorder (BD) during their depressive episodes by circadian biomarkers in patient’s peripheral blood?
Findings
In this case-control study of 100 participants, serum PER1 levels were significantly decreased in the MDD group but were significantly increased in the BPD group, serum PER2 levels were significantly elevated in both MDD and BPD groups, and serum pCREB levels were significantly increased in the BPD group, compared with the HC group. Besides, In the MDD group, serum PER1 levels were significantly positively associated with mood disorder questionnaire (MDQ) scores; and serum pCREB levels were significantly negatively associated with MDQ scores. In the BPD group, serum pCREB levels were significantly negatively associated with HAMD-17 scores. The combined use of serum pCREB and PER1 and the three biomarkers (pCREB, PER1 and PER2) had similar diagnostic values in differentiating MDD from BPD.
Meaning
The serum PER1 has great value for differentiating MDD from BPD, and combined use of serum biomarkers of pCREB/PER1 or pCREB/PER1/PER2 shows higher efficacy in differentiating MDD from BPD.
